Financhill
Back

Arvinas Vs. Kymera Therapeutics Industry Stock Comparison

Sell
41

ARVN
Arvinas

Last Price:
25.15
Seasonality Move:
-12.32%
Buy
73

KYMR
Kymera Therapeutics

Last Price:
48.52
Seasonality Move:
1.07%
Sell
41
Arvinas (ARVN) is a Sell

Is Arvinas a Buy, Sell or Hold?

  • The current Arvinas [ARVN] share price is $25.00. The Score for ARVN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ARVN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $46.50. The Score for KYMR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ARVN Stock Price Chart

What is Arvinas's stock price today?

  • The Arvinas share price today is $25.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARVN is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $46.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.

ARVN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 44.03 Sell
Chaikin Money Flow: -326339 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.61 - 28.87) Sell
Bollinger Bands (100): (25.68 - 34.64) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.34 Buy
Relative Strength Index (14 RSI): 62.83 Buy
Chaikin Money Flow: 417171 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.57 - 45.01) Buy
Bollinger Bands (100): (32.37 - 41.77) Buy

ARVN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.8 Buy
20-day SMA: 26.05 Sell
50-day SMA: 26.54 Sell
200-day SMA: 33.64 Sell
8-day EMA: 25.06 Sell
20-day EMA: 25.79 Sell
50-day EMA: 27.37 Sell
200-day EMA: 31.23 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.55 Buy
20-day SMA: 43.13 Buy
50-day SMA: 38.73 Buy
200-day SMA: 33.41 Buy
8-day EMA: 44.01 Buy
20-day EMA: 42.81 Buy
50-day EMA: 40.25 Buy
200-day EMA: 34.43 Buy

Arvinas Earnings Growth & ARVN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.65 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.

Arvinas Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):